<!--
    Copyright 2016 DLR - German Aerospace Center
   
    Licensed under the Apache License, Version 2.0 (the "License");
    you may not use this file except in compliance with the License.
    You may obtain a copy of the License at
   
    http://www.apache.org/licenses/LICENSE-2.0
   
    Unless required by applicable law or agreed to in writing, software
    distributed under the License is distributed on an "AS IS" BASIS,
    WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
    See the License for the specific language governing permissions and
    limitations under the License.
 -->
<documents>
	<document>
		<id>1004153</id>
		<title>Large-Scale Chemical Similarity Networks for Target Profiling of Compounds Identified in Cell-Based Chemical Screens</title>
		<description>
		Target identification is one of the most critical steps following cell-based phenotypic chemical screens aimed at identifying compounds with potential uses in cell biology and for developing novel disease therapies. Current in silico target identification methods, including chemical similarity database searches, are limited to single or sequential ligand analysis that have limited capabilities for accurate deconvolution of a large number of compounds with diverse chemical structures. Here, we present CSNAP (Chemical Similarity Network Analysis Pulldown), a new computational target identification method that utilizes chemical similarity networks for large-scale chemotype (consensus chemical pattern) recognition and drug target profiling. Our benchmark study showed that CSNAP can achieve an overall higher accuracy (>80%) of target prediction with respect to representative chemotypes in large (>200) compound sets, in comparison to the SEA approach (60â€“70%). Additionally, CSNAP is capable of integrating with biological knowledge-based databases (Uniprot, GO) and high-throughput biology platforms (proteomic, genetic, etc) for system-wise drug target validation. To demonstrate the utility of the CSNAP approach, we combined CSNAP's target prediction with experimental ligand evaluation to identify the major mitotic targets of hit compounds from a cell-based chemical screen and we highlight novel compounds targeting microtubules, an important cancer therapeutic target. The CSNAP method is freely available and can be accessed from the CSNAP web server (http://services.mbi.ucla.edu/CSNAP/).
		</description>
		<publishDate>March 31, 2015</publishDate>
		<externalLink>http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1004153</externalLink>
		<publisher>PLOS</publisher>
		<authors>Yu-Chen Lo,Silvia Senese,Chien-Ming Li,Qiyang Hu,Yong Huang,Robert Damoiseaux,Jorge Z. Torres</authors>
		<categoriesText>tubulins,cluster compounds,drug discovery,drug interactions,colchicine,microtubules,polmerization,database searching</categoriesText>
		<keywordsText>cluster, database, drug, discovery</keywordsText>
		<license>CC-BY 4.0 http://creativecommons.org/licenses/by/4.0/legalcode</license>
			</document>

</documents>